Pubmed ID: 32008359

Pubmed Central ID: PMC7006690

Journal: Circulation. Cardiovascular quality and outcomes

Publication Date: Feb. 1, 2020

Affiliation: Division of Cardiovascular Medicine, Department of Medicine (E.H., C.J.P., R.M.C.-D.), College of Medicine, University of Florida, Gainesville.

MeSH Terms: Humans, Risk Factors, United States, Hypertension, Randomized Controlled Trials as Topic, Terminology as Topic, Treatment Outcome, Blood Pressure, Practice Guidelines as Topic, Time Factors, Predictive Value of Tests, Drug Therapy, Combination, Antihypertensive Agents, American Heart Association, Drug Resistance

Grants: K01 HL138172, R01 HL033610, R01 HL132448

Authors: Gurka MJ, Smith SM, Pepine CJ, Cooper-DeHoff RM, Winterstein AG, Handberg E

Cite As: Smith SM, Gurka MJ, Winterstein AG, Handberg E, Pepine CJ, Cooper-DeHoff RM. Redefining Resistant Hypertension: A Comparison of Cardiovascular Risk Associated With the 2018 Versus 2008 American Heart Association Definitions for Resistant Hypertension. Circ Cardiovasc Qual Outcomes 2020 Feb;13(2):e005979. Epub 2020 Feb 3.

Studies:

• Action to Control Cardiovascular Risk in Diabetes (ACCORD)
• Systolic Blood Pressure Intervention Trial (SPRINT)